Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’
The world’s first drug to delay the onset of type 1 diabetes is to be made available on the NHS in England and Wales, in the biggest breakthrough in tackling the disease for more than a century.
Millions of people have type 1 diabetes worldwide, which typically emerges during childhood or adolescence, and occurs when the pancreas makes little or no insulin. Insulin is a hormone the body uses to allow glucose to enter cells to produce energy.
Continue reading...
TH
Source
This article was originally published by The Guardian and written by Andrew Gregory Health editor.
Read original article on The Guardian